Scaffold-based design of kinase inhibitors for cancer therapy

Current Opinion in Genetics & Development
Chao Zhang, Gideon Bollag

Abstract

Kinase inhibitors have already established a foothold in the current armament for the treatment of malignancies. Indeed, the future of cancer therapy is likely to rely heavily on an ever-growing number of kinase inhibitors, either as single-agents or in combination with other targeted drugs or even chemotherapies. The progress of the past decade has been driven increasingly by improvements in an integrated drug discovery paradigm that starts with smaller molecular starting points, termed scaffolds, and incorporates X-ray crystallography at the outset of the project. Guided throughout by structural information, the medicinal chemistry efforts are streamlined and enhanced. Here, we review such a paradigm termed scaffold-based design and show how implementation of these methods results in novel, potent, and specific drug candidates.

References

Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jul 18, 2002·Nature Reviews. Drug Discovery·Margaret A Somerville
Dec 10, 2002·Science·G ManningS Sudarsanam
Mar 20, 2004·Science·Martin E M NobleLouise N Johnson
Mar 24, 2004·Cell·Paul T C WanUNKNOWN Cancer Genome Project
Oct 19, 2004·Cancer Cell·Mathew J Garnett, Richard Marais
Jan 22, 2005·Journal of Medicinal Chemistry·Michael J HartshornHarren Jhoti
Jan 25, 2005·Molecular Cell·Michele K DoughertyDeborah K Morrison
Feb 16, 2005·Nature Biotechnology·Miles A FabianDavid J Lockhart
Aug 13, 2005·Cell Cycle·Massimo LibraJames A McCubrey
Nov 8, 2005·Nature·David B SolitNeal Rosen
Mar 29, 2006·Melanoma Research·Nancy E Thomas
Nov 3, 2006·Current Opinion in Structural Biology·Patricia Pellicena, John Kuriyan
Nov 7, 2006·Current Opinion in Structural Biology·Zhengshuang ShiNatalie G Ahn
Mar 27, 2007·Nature Reviews. Cancer·Suzanne SchubbertGideon Bollag
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Floriana MorgilloHo-Young Lee
Aug 28, 2007·Chemical Biology & Drug Design·Tianjun ZhouXiaotian Zhu
Dec 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·James BeanWilliam Pao
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·James TsaiGideon Bollag
Jun 27, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lecia V Sequist
Jul 16, 2008·Bioorganic & Medicinal Chemistry Letters·Andrew K TakleDavid M Wilson
Sep 4, 2008·Molecular Cancer Therapeutics·Paul HaluskaCharles Erlichman
Sep 17, 2008·Nature Structural & Molecular Biology·Mohammad AzamGeorge Q Daley
Oct 24, 2008·Journal of Medicinal Chemistry·Savithri RamurthyPaul A Renhowe
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichGeorge D Demetri
Nov 1, 2008·Molecular Cancer Therapeutics·Thomas Bachleitner-HofmannMartin R Weiser
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Jan 6, 2009·Drug Discovery Today·Irini Akritopoulou-Zanze, Philip J Hajduk
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ketan S GajiwalaGeorge D Demetri
Feb 17, 2009·Cancer Letters·Clara Montagut, Jeff Settleman
Apr 28, 2009·Nature Chemical Biology·Jeffrey R SimardDaniel Rauh
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Jun 6, 2009·Expert Review of Anticancer Therapy·Lorenza Rimassa, Armando Santoro
Jul 3, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Jul 17, 2009·Surgical Neurology·Christopher J Carrubba, Todd W Vitaz

❮ Previous
Next ❯

Citations

Oct 13, 2012·Nature Reviews. Drug Discovery·Gideon BollagPeter Hirth
Oct 11, 2011·Bioscience Reports·Rolando Pérez-Lorenzo, Bin Zheng
Apr 27, 2013·Expert Review of Anticancer Therapy·Heather M Shaw, Paul D Nathan
May 26, 2018·Annual Review of Genomics and Human Genetics·Sarine MarkossianMichelle R Arkin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Eric W JosephNeal Rosen
Cold Spring Harbor Protocols
John G Clohessy, Elisa de Stanchina
BMC Medical Informatics and Decision Making
Peter Wanger, Lene Martin
© 2022 Meta ULC. All rights reserved